ENTERAL VS IV FEEDING--EFFECT ON MUCOSAL IMMUNITY
肠内喂养与静脉内喂养——对粘膜免疫的影响
基本信息
- 批准号:2467578
- 负责人:
- 金额:$ 20.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-01 至 2002-01-31
- 项目状态:已结题
- 来源:
- 关键词:Pseudomonas aeruginosa Streptococcus pneumoniae arginine cytokine diet enzyme linked immunosorbent assay glutamine gut associated lymphoid tissue human therapy evaluation immunoglobulin A influenzavirus A interleukin 4 interleukin 5 interleukin 6 laboratory mouse mucosal immunity neuropeptides nutrition related tag parenteral feedings respiratory system transforming growth factors tube feeding
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Inexpensive therapies
which reduce septic complications of critically ill patients could greatly
impact the $5-10 billion spent annually in the U.S. on these complications.
Enteral feeding significantly reduces the complication of pneumonia compared
with intravenous (IV-TPN) feeding through unknown defense mechanisms. Data
from our laboratory demonstrates that IV-TPN or an elemental diet (ED)
impairs mucosal immunity through atrophy of the gut-associated lymphoid
tissue (GALT) in the mouse and reduction of IgA, the major effector arm of
mucosal immunity. IgA-dependent antiviral defenses in the respiratory tract
are maintained with any form of enteral feeding but deteriorate with IV
feeding. This proposal focuses on the effect of route and type of nutrient
administration, of gut-specific nutrients (arginine and glutamine), and
various neuropeptides on IgA-mediated defenses in the GI and the respiratory
tract. Following dietary manipulation with GALT-depleting (IV or ED) or
GALT-maintaining diets (chow or complex enteral diet), immunized mice will
be challenged in models of viral (PR8) or bacterial (Ps. aeruginosa and St.
pneumoniae) pneumonia models. Immune animals with normal GALT systems avoid
fatal pneumonitis while nonimmune or immunoincompetent die. Their
hypothesis is that a diet-induced atrophy of the GALT impairs the ability of
the respiratory tract to withstand a severe infectious challenge through
depressed extraintestinal mucosal defenses after dietary, neuropeptide or
specialty nutrient manipulation. GALT cells will be analyzed for changes in
cytokine production or message of IgA stimulating (IL-4, IL-5, IL-6, and
TGF-beta) and IgA-inhibiting (IFN and TNF-beta) cytokines. The specific
aims are to: investigate factors influencing mucosal defenses; define
permutations in defenses after nutrient and neuropeptide manipulations; and
to challenge these manipulated defenses with clinically applicable in vivo
infectious agents. The main hypothesis is that dietary manipulations which
impair the GALT also impairs normal mucosal defenses and that dietary,
neuropeptide, or specialty nutrient manipulations which normalize GALT also
normalize IgA-mediated mucosal defense and the GALT cytokine milieu.
描述(改编自申请人摘要):廉价疗法
减少重症患者的脓毒性并发症,
美国每年花费在这些并发症上的50 - 100亿美元。
肠内喂养显著减少肺炎并发症,
静脉(IV-TPN)喂养通过未知的防御机制。 数据
我们实验室的研究表明,IV-TPN或元素饮食(艾德)
通过肠道相关淋巴萎缩损害粘膜免疫
组织(GALT)在小鼠和减少伊加,主要效应臂的
粘膜免疫 呼吸道中IgA依赖性抗病毒防御
任何形式的肠内喂养都能维持,但静脉注射会恶化
喂食 该建议侧重于营养素途径和类型的影响
肠特异性营养素(精氨酸和谷氨酰胺)的施用,以及
各种神经肽对IgA介导的胃肠道和呼吸道防御的影响
道。 在饮食控制和GALT消耗(IV或艾德)后,或
GALT维持饮食(食物或复合肠内饮食),免疫小鼠将
在病毒(PR 8)或细菌(Ps.)模型中受到挑战。 aeruginosa和St.
肺炎)肺炎模型。 具有正常GALT系统的免疫动物避免
致命性肺炎,而非免疫或免疫功能不全死亡。 他们的
一种假说是饮食诱导的GALT萎缩损害了
呼吸道抵御严重的感染性挑战,
饮食、神经肽或
专业营养调控 将分析GALT细胞的变化,
伊加刺激的细胞因子产生或信息(IL-4、IL-5、IL-6和
TGF-β)和IgA抑制(IFN和TNF-β)细胞因子。 具体
目的是:调查影响粘膜防御的因素;定义
营养素和神经肽操纵后的防御排列;以及
用临床上适用的体内试验来挑战这些被操纵的防御
传染源 主要的假设是,
损害GALT也损害正常的粘膜防御,
神经肽,或特殊的营养操作,使GALT正常化,
使IgA介导的粘膜防御和GALT细胞因子环境正常化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(5)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH A KUDSK其他文献
KENNETH A KUDSK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH A KUDSK', 18)}}的其他基金
Route of Nutrition and Enteric Nervous System Effects on Innate Mucosal Defense
营养途径和肠神经系统对先天粘膜防御的影响
- 批准号:
8326881 - 财政年份:2012
- 资助金额:
$ 20.05万 - 项目类别:
Route of Nutrition and Enteric Nervous System Effects on Innate Mucosal Defense
营养途径和肠神经系统对先天粘膜防御的影响
- 批准号:
8449952 - 财政年份:2012
- 资助金额:
$ 20.05万 - 项目类别:
Route of Nutrition and Enteric Nervous System Effects on Innate Mucosal Defense
营养途径和肠神经系统对先天粘膜防御的影响
- 批准号:
8698321 - 财政年份:2012
- 资助金额:
$ 20.05万 - 项目类别:
Enteral vs. IV Feeding: Effect on Mucosal Immunity
肠内喂养与静脉注射喂养:对粘膜免疫的影响
- 批准号:
7265813 - 财政年份:1999
- 资助金额:
$ 20.05万 - 项目类别:
Enteral vs. IV Feeding: Effect on Mucosal Immunity
肠内喂养与静脉注射喂养:对粘膜免疫的影响
- 批准号:
7626045 - 财政年份:1999
- 资助金额:
$ 20.05万 - 项目类别:
Enteral vs. IV Feeding: Effect on Mucosal Immunity
肠内喂养与静脉注射喂养:对粘膜免疫的影响
- 批准号:
7780438 - 财政年份:1999
- 资助金额:
$ 20.05万 - 项目类别:
Enteral vs. IV Feeding: Effect on Mucosal Immunity
肠内喂养与静脉注射喂养:对粘膜免疫的影响
- 批准号:
7388259 - 财政年份:1999
- 资助金额:
$ 20.05万 - 项目类别:
ENTERAL VS IV FEEDING--EFFECT ON MUCOSAL IMMUNITY
肠内喂养与静脉内喂养——对粘膜免疫的影响
- 批准号:
6500948 - 财政年份:1998
- 资助金额:
$ 20.05万 - 项目类别:
ENTERAL VS IV FEEDING--EFFECT ON MUCOSAL IMMUNITY
肠内喂养与静脉内喂养——对粘膜免疫的影响
- 批准号:
6351202 - 财政年份:1998
- 资助金额:
$ 20.05万 - 项目类别:
Enteral vs IV Feeding: Effect on Mucosal Immunity
肠内喂养与静脉注射喂养:对粘膜免疫的影响
- 批准号:
6470391 - 财政年份:1998
- 资助金额:
$ 20.05万 - 项目类别:
相似海外基金
Identifying the correlates of protection against Streptococcus pneumoniae respiratory tract infection using a human challenge model
使用人体挑战模型确定预防肺炎链球菌呼吸道感染的相关性
- 批准号:
MR/Z503721/1 - 财政年份:2024
- 资助金额:
$ 20.05万 - 项目类别:
Research Grant
The impact of thermally-regulated cell wall modifications on Streptococcus pneumoniae pathogenesis
热调节细胞壁修饰对肺炎链球菌发病机制的影响
- 批准号:
MR/X009130/1 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
Research Grant
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
- 批准号:
10639102 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
ISS: Exploiting the Space Environment to Dissect the Molecular Basis of Streptococcus pneumoniae (Spn) Cardiotoxicity”
国际空间站:利用太空环境剖析肺炎链球菌 (Spn) 心脏毒性的分子基础 —
- 批准号:
2223072 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
Standard Grant
Understanding how penicillin resistance develops in Streptococcus pneumoniae clinical populations
了解肺炎链球菌临床人群中青霉素耐药性如何发展
- 批准号:
2902003 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
Studentship
Small RNA based control of zinc homeostasis in Streptococcus pneumoniae
基于小RNA的肺炎链球菌锌稳态控制
- 批准号:
10625448 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
THE IMPACT OF ADVANCED AGE AND SEX ON HUMORAL IMMUNITY TO STREPTOCOCCUS PNEUMONIAE
高龄和性别对肺炎链球菌体液免疫的影响
- 批准号:
10532071 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequences
肺炎链球菌全基因组的进化本质及其机制和进化后果
- 批准号:
10503286 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
TNF impairs macrophage killing of Streptococcus pneumoniae
TNF 损害巨噬细胞对肺炎链球菌的杀伤作用
- 批准号:
475472 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Studentship Programs
Utilization of the adjuvant effect of CRM197 protein to develop a trivalent protein-vaccine against Streptococcus pneumoniae infections
利用CRM197蛋白的佐剂作用开发抗肺炎链球菌感染的三价蛋白疫苗
- 批准号:
10552114 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别: